Baccelli I, Batty C, Biteau K, Drouin M, Evrard B, Gauttier V, Ligeron C, Mary C, Merieau E, Poirier N, Wilhelm E, Saenz J. 2024. CLEC-1 restrains acute inflammatory response and recruitment of neutrophils following tissue injury. Journal of Immunology 212 (7): 1178-1187. DOI:
https://doi.org/10.4049/jimmunol.2300479.
Badiei Z, Sholevar F, Asadzadeh A. 2017. Bioinformatics study of the anticancer effect of black seed active ingredient. Fifth National Conference on Innovation and Technology in Life Sciences, Tehran. Available at:
https://civilica.com/doc/1425991. (In Farsi)
Bag A, Bhattacharyya SK, Chattopadhyay RR. 2013. The development of
Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pacific Journal of Tropical Biomedicine 3 (3): 244-252. DOI:
http://dx.doi.org/10.1016/S2221-1691(13)60059-3.
Baranauskienė L, Kairys V, Kazlauskienė M, Kazlauskas E, Matulis D. 2019. Binding affinity in drug design: experimental and computational techniques. Expert Opinion on Drug Discovery 14 (8): 755-768. DOI:
https://doi.org/10.1080/17460441.2019.1623202.
Borges L, Kubin M, Kuhlman T. 2003. LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule. Blood 101 (4): 1484-1486. DOI:
https://doi.org/10.1182/blood-2002-05-1432.
Cancrini C, Cifaldi L, Cotugno N, Doria M, Palma P, Rossi P, Zicari S. 2019. DNAM-1 activating receptor and its ligands: How do viruses affect the NK cell-mediated immune surveillance during infection? International Journal of Molecular Sciences 20 (15): 3715. DOI:
https://doi.org/10.3390/ijms20153715.
Chapman J, Zhang Y. 2023. Histology, Hematopoiesis. StatPearls [Internet], National Library of Medicine (National Center for Biotechnology Information), Bookshelf ID: NBK534246.
Chopra B, Dhingra A, Grewal A, Guarve K. 2022. Pharmacological properties of Chebulinic acid and related ellagitannins from nature: An emerging contemporary bioactive entity. Pharmacological Research – Modern Chinese Medicine 5: 100163. DOI:
https://doi.org/10.1016/j.prmcm.2022.100163.
Daoud I, Ghalem S, Mesli F. 2019. Antidiabetic activity of Nigella sativa (black seed): molecular modeling, molecular dynamic, and conceptual DFT investigation. Pharmacophore 10 (5): 57-66.
Dhanda S, Kaur K, Monga I. 2022. Revisiting hematopoiesis: applications of bulk and single-cell transcriptomics dissecting transcriptional heterogeneity in hematopoietic stem cells. Briefings in Functional Genomics 21 (3): 159-176. DOI:
https://doi.org/10.1093/bfgp/elac002.
Gandomdoust N. 2020. Identification and repositioning of effective medicinal plants in the treatment of fatty liver using a bioinformatics approach. MSc Thesis, Imam Khomeini International University, 68-69. (In Farsi)
Han L, Hu X, Liu H, Gao Y, Leak R, Zhang K, Yang T, Yin K, Zhang X. 2017. Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair. Progress in Neurobiology 163-164: 27-58. DOI:
https://doi.org/10.1016/j.pneurobio.2017.10.002.
Hünig T, Köhler C, Lottspeich F, Mitnacht R, Meuer S, Tiefenthaler G. 1987. The “erythrocyte receptor” of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation. Journal of Neuro-Oncology 81: 31-40.
Li D, Chen K, Sinha N, Zhang X, Wang Y, Sinha AK, Romeo F, Mehta JL. 2005. The effects of PPAR-γ ligand pioglitazone on platelet aggregation and arterial thrombus formation. Cardiovascular Research 65 (4): 907-912. DOI:
https://doi.org/10.1016/j.cardiores.2004.11.027.
Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. 2001. Estrogen Receptor-β potency-selective ligands: structure–activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. Journal of Medicinal Chemistry 44 (24): 4230-4251. DOI:
https://doi.org/10.1021/jm010254a.
Moraes DA, Sibov TT, Pavon LF, Alvim PQ, Bonadio RS, Da Silva JR, Pic-Taylor A, Toledo OA, Marti LC, Azevedo RB, Oliveira DM. 2016. A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells. Stem Cell Research & Therapy 7 (1): 97. DOI:
https://doi.org/10.1186/s13287-016-0359-3.
Santana-Sánchez P, Vaquero-García R, Legorreta-Haquet MV, Chávez-Sánchez L, Chávez-Rueda AK. 2024. Hormones and B-cell development in health and autoimmunity. Frontiers in Immunology 15: 1385501. DOI:
https://doi.org/10.3389/fimmu.2024.1385501.
Seita J, Weissman I. 2010. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2 (6): 640-653. DOI:
https://doi.org/10.1002/wsbm.86.
Shin JY, Hu W, Naramura M, Park CY. 2014. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. The Journal of Experimental Medicine 211 (2): 217-231. DOI:
https://doi.org/10.1084/jem.20131128.
Yao G, Miao X, Wu M, Lv Z, Bai Y, Chang Y, Ouyang H, and He J. 2023. Pharmacokinetics of active compounds of a
Terminalia chebula Retz. ethanolic extract after oral administration in rats using UPLC-MS/MS. Frontiers in Pharmacology 14: 1067089. DOI:
https://doi.org/10.3389/fphar.2023.1067089.
)